Showing 1 posts of 1 posts found.
Biotech firm CAP-CMV which is a spin-out of CEVEC Pharmaceuticals has appointed industry veteran Dr Albrecht Läufer as its chief …
Long-acting therapies set to reshape HIV treatment market
MHRA authorises Lynkuet for hot flushes linked to breast cancer therapy
MHRA approves Romvimza for tenosynovial giant cell tumour
NICE recommends allergy immunotherapy tablets for younger children
Dunbar Pharmaceuticals and IPS Pharma announce distribution agreement